<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01538108</url>
  </required_header>
  <id_info>
    <org_study_id>NMB AVS P</org_study_id>
    <nct_id>NCT01538108</nct_id>
  </id_info>
  <brief_title>Study of NMB (Company's Name) Drug Ejecting Balloon for Arteriovenous Fistulae</brief_title>
  <official_title>The Use of NMB Drug Ejecting Balloon for Arteriovenous (AV) Dialysis Fistulae</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>N.M.B. Medical Applications Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>N.M.B. Medical Applications Ltd</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to demonstrate the safety and effectiveness of the use of NMB's
      percutaneous transluminal angioplasty (PTA) Balloon.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Restenosis Rate</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Restenosis rate</measure>
    <time_frame>1,3 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Easy insertion and removal</measure>
    <time_frame>intraprocedural</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major adverse events</measure>
    <time_frame>intraprocedural, 1, 3, 6 and 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Obstructive Lesions of Arteriovenous Dialysis Fistulae</condition>
  <arm_group>
    <arm_group_label>NMB's PTA Balloon catheter with paclitaxel</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Angioplasty Balloon</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PTA Balloon catheter with paclitaxel</intervention_name>
    <description>patients treated by the NMB's PTA Balloon catheter with paclitaxel</description>
    <arm_group_label>NMB's PTA Balloon catheter with paclitaxel</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Plain Balloon angioplasty (PBA)</intervention_name>
    <description>PBA</description>
    <arm_group_label>Standard Angioplasty Balloon</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients 18 years and older

          -  Patients with arteriovenous fistula with obstructive lesion

          -  Patient who is willing and able to sign a written informed consent

        Exclusion Criteria:

          -  age &lt; 18

          -  female with child bearing potential

          -  Previous participation in another study with any investigational drug or device within
             the past 30 days

          -  Life expectancy of less than 12 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Uri Rimon, MD</last_name>
    <phone>972-3-5302530</phone>
    <email>Uri.Rimon@sheba.health.gov.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Chaim Sheba Medical Center</name>
      <address>
        <city>Tel Hashomer</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Uri Rimon, MD</last_name>
      <phone>972-3-5302530</phone>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>February 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 15, 2012</study_first_submitted>
  <study_first_submitted_qc>February 22, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 23, 2012</study_first_posted>
  <last_update_submitted>February 22, 2012</last_update_submitted>
  <last_update_submitted_qc>February 22, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 23, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fistula</mesh_term>
    <mesh_term>Arteriovenous Fistula</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paclitaxel</mesh_term>
    <mesh_term>Albumin-Bound Paclitaxel</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

